Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-17

FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Travoprost Ophthalmic Solution under an Original ANDA filed by Alembic Pharmaceuticals, indicated to reduce intraocular pressure in open-angle glau…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRAVOPROST OPHTHALMIC SOLUTION (Travoprost)

Snippet

ORIG AP for TRAVOPROST OPHTHALMIC SOLUTION (TRAVOPROST OPHTHALMIC)